Today on in-pharmatechnologist.com   Excipient market set to change, says report Siegfried and Arena sign contract manufacturing deal Chao Centre gets rights to manufacture TB drug Patheon reveals plans to tackle Puerto Rico problems Japan says Tamiflu/psychiatric link unclear

Related Industry News   NIH cash for new tools to unravel genome's secrets Harvard Bioscience knocks back Skystone takeover bid Oxford Genome Sciences advances on Amgen deal Semen fibrils ferry HIV into cells

		In association with
Breaking News on Pharmaceutical Technology
Daily  Tuesday 18 December 2007		Forward to a colleague

	Product Brochure Maximum flexibility and high speed with the new MCPV850. Presenting the first Marchesini case packer & palletiser to have a vertical case packer, combining in a single compact block the two operations consisting of vertical case packing and palletizing... Click Here Access Full Stories Excipient market set to change, says report Advances in the pharmaceutical industry are expected to have an impact on pharmaceutical excipients within the next decade, a new report claims... Read Siegfried and Arena sign contract manufacturing deal Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride... Read Chao Centre gets rights to manufacture TB drug Eli Lilly has handed over the manufacturing reins of the antibiotic Seromycin to the Chao Centre for Industrial Pharmacy and Contract Manufacturing... Read Patheon reveals plans to tackle Puerto Rico problems Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability... Read Japan says Tamiflu/psychiatric link unclear Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government... Read
	All News Headlines for: December | November | October
	Company Profile Bonfiglioli Engineering - quality and innovation for the pharma industry. Bonfiglioli Engineering has become a global player in the medical arena offering a wide range of leak testing machines complying with FDA regulations... Click Here
	Related Industry News NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Harvard Bioscience knocks back Skystone takeover bid Harvard Bioscience has rejected an unsolicited acquisition offer from Skystone Advisors to acquire all outstanding shares of common stock in the life science tools and instrument manufacturer... Read Oxford Genome Sciences advances on Amgen deal Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech... Read Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Product Presentation Technically flawless packaging with practical designs Bormioli Rocco adopts the most sophisticated technology for pharmaceutical packaging, using glass and plastic, in order to grant the essential property of chemical stability, precision of size and durability... Click Here Previous Headlines Pronova and FMC to develop seaweed-derived capsules Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology... Read Double whammy as Merck kids' vaccines recalled and suspended Merck has been hit with a contamination threat prompting the recall of a million of its childhood Hib vaccines across the US, right alongside the Canadian suspension of its MMR vaccine... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read Novartis launches initiative with 2,500 job losses Novartis is to sever a further 2,500 jobs as part of a new initiative aimed to 'improve competitiveness in a dynamically changing healthcare environment'... Read China's API manufacturers facing further crackdowns The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Sensitive and selective with IC-MS coupling - Technical / White Paper Product Information - brochures, Web centers Transdermal Sufentanil Licensing Opportunity - Application Notes Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com